查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
多囊性卵巢症候群的全球市場:預測(2022年～2028年)
市場調查報告書
商品編碼
1123162

多囊性卵巢症候群的全球市場:預測(2022年～2028年)

Global Polycystic Ovary Syndrome Market Research and Forecast 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

全球多囊性卵巢症候群的市場規模在預測期間內預計將以約4.0％年複合成長率擴大。促進市場增長的主要因素是久坐不動的生活方式、不良的飲食習慣以及世界上越來越多的肥胖女性。政府和非營利組織為提高對這種疾病的早期診斷的認識所做的努力正在顯著推動市場的增長。

本報告提供全球多囊性卵巢症候群市場相關調查，提供市場概要，以及各藥物類型，各診斷類型，各治療類型，各流通管道，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 報告概要

第2章 市場概要與洞察

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
  • 主要策略分析
  • COVID-19對主要加入企業帶來的影響

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 機會

第5章 市場區隔

  • 全球多囊性卵巢症候群市場，各藥物類型
    • 利尿劑
    • 胰島素增敏劑
    • 抗雄激素
    • 抗抑鬱藥
    • 鳥氨酸脫羧酶抑製劑
    • 抗肥胖
    • 口服避孕藥
  • 全球多囊性卵巢症候群市場，各診斷類型
    • 超音波
    • 婦科檢查
    • 血液檢驗
  • 全球多囊性卵巢症候群市場，各治療類型
    • 卵巢楔子書切除術
    • 腹腔鏡下卵巢開孔術
    • 針灸治療
  • 全球多囊性卵巢症候群市場，各流通管道
    • 院內藥局
    • 零售藥局(線上及離線)
    • 不孕治療診所

第6章 地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • AVA Science Inc.
  • Bayer AG
  • Bristol-Myers Squibb Co.
  • Dexa Medica(Dexa Group)
  • Ferring B.V.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Millendo Therapeutics, Inc.
  • MyOva
  • Novartis AG
  • PCOS Diva LLC
  • Pharmasure Ltd.
  • Sanofi SA
  • Sneha Natura
  • Teva Pharmaceutical Industries Ltd.
  • The Himalaya Drug Co.
  • Theralogix, LLC
Product Code: OMR2018292

Global Polycystic Ovary Syndrome (PCOS) Market Size, Share & Trends Analysis Report By Drug Type (Diuretics, Insulin Sensitizing Agents, Antiandrogens, Anti-Depressants, Ornithine Decarboxylase Inhibitors, and Others), By Diagnosis (Ultrasound, Pelvic Exam, and Others) By Treatment (Ovarian Wedge Resection, Laparoscopic Ovarian Drilling, and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies (Online And Offline), And Fertility Clinics) Forecast, 2021-2027

The global market for PCOS is projected to have a considerable CAGR of around 4.0% during the forecast period. Polycystic ovary syndrome is a hormonal disorder observed in females of reproductive ages. The disorder causes the excessive production of hormones in the female body, which include testosterone or androgens, hormones that are primarily associated with the male reproductive system. PCOS includes a range of symptoms such as irregular menstrual cycle, trouble in getting pregnant, cyst formation in the ovaries, excessive body and facial hair, and pelvic pain, among others. Moreover, the early diagnosis of the disorder is highly recommended by the physicians, as untreated PCOS may often lead to high cholesterol, type-2 diabetes, heart disease, insulin resistance, and high blood pressure. Major factors contributing to the growth of the global polycystic ovary syndrome market include a sedentary lifestyle and faulty dietary habits and an increasing female obese population across the globe. Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder are significantly fueling the market growth.

Moreover, increasing genetic and hormonal disorder in the female population is a major cause for the increase of polycystic ovary syndrome patients across the globe. The cost associated with the treatment of PCOS is the major factor affecting the growth of the market. According to the National Institute of the Health report, the cost to the US healthcare system to identify and manage PCOS is approximately $4 billion annually. However, the lack of regulatory approved drugs for the treatment of PCOS and easy availability of generic and off-label drugs may restrain the growth of the global PCOS market. However, market players are focusing on the development of innovative and symptom-specific drugs that are expected to fuel market growth in the near future.

Impact of COVID-19 on Global PCOS Market

The COVID-19 pandemic negatively affected the global PCOS market. As lockdown was announced by the government of major economies due to which essentials services and transportation facilities were put on halt. On the other hand, many gynecological procedures and nonessential treatments for PCOS were postponed. Even the new products and launches of products and drugs for the treatment of PCOS were canceled. This led to a decline in market growth. Besides, disruption in raw material supply from China was also witnessed during the pandemic, due to which the various drug development companies experienced major loss and fewer products in the pipeline. All these factors affected the market growth.

Segmental Outlook

The global PCOS market is segmented based on drug type, diagnosis, treatment, and distribution channel. Based on drug type, the market is segmented into diuretics, insulin-sensitizing agents, antiandrogens, anti-depressants, ornithine decarboxylase inhibitors, anti-obesity, and oral contraceptive pills. Among these, the insulin-sensitizing agents hold a major share owing to the wide adoption of the drug for the treatment of insulin resistance, to prevent diabetes which is one of the major causes of PCOS. Based on the diagnosis, the market is further classified into ultrasound, pelvic exam, and blood test. Whereas, the treatment segment is categorized into ovarian wedge resection, laparoscopic ovarian drilling, and acupuncture. Similarly, based on distribution channels, the global PCOS market is segmented into hospital pharmacies, retail pharmacies (online and offline), and fertility clinics.

Global PCOS Market Share by Treatment, 2020 (%)

Global PCOS Market Share by Treatment

Laparoscopic Ovarian Drilling is Expected to Dominate the PCOS Market

Based on treatment, laparoscopic ovarian drilling dominated the market and it is projected to grow at significant CAGR during the forecast period. The rising prevalence of polycystic ovarian syndrome is the major factor driving the growth of the market. According to the Centers for Disease Control and Prevention, approximately 5 million women of reproductive age suffer from the polycystic ovarian syndrome. The increasing prevalence of PCOS creating the demand for advanced and cost-effective treatments such as laparoscopic ovarian drilling. Laparoscopic ovarian drilling is a surgical treatment that can trigger ovulation in women having PCOS and can destroy the parts of ovaries by electrocautery or a laser. Pregnancy success rates in the first year in women after ovarian drilling range surgery at around 50% according to the American Society for Reproductive Medicine. Due to these factors, the segment is expected to grow during the forecast period.

Regional Outlook

Geographically, the global PCOS market is classified into four major regions including North America (the US and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia-Pacific), and Rest of the World (Latin America and the Middle East and Africa (MEA)). Among these, Asia-Pacific is projected to exhibit the fastest growth in the global PCOS market during the forecast period. This is due to the large pool of female obese population in the region, especially in China. The presence of a large patient pool, government awareness programs regarding the growing prevalence of PCOS, and advancement in cost-effective treatments for PCOS are the major factors driving the growth of the market during the forecast period.

Global PCOS Market Growth, by Region 2021-2027

Global PCOS Market Growth, by Region

North America Holds the dominant Position in the Global PCOS market

Geographically, North America held the largest share in 2020, and it is projected to dominate the market during the forecast period. This is mainly owing to the rising prevalence of PCOS disorder, and the large presence of the obese female population. According to the CDC, in the US, PCOS is one of the most common causes of female infertility, affecting 6% to 12% (as many as 5 million) of Women. This increasing prevalence creating the strong demands for an effective treatment for PCOS. Moreover, high reimbursement policies by the government in the healthcare sector and awareness amongst the population regarding the early diagnosis of the disorder, and adoption of minimal invasive surgeries (MIS) are significantly contributing towards the market growth in the region.

Market Players Outlook

The key players in the global PCOS market contributing significantly by providing different types of products and increasing their geographical presence across the globe. The key players of the market are Abbott Laboratories, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., Ferring Pharmaceuticals, Merck & Co., Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., among others. These market players adopt different marketing strategies such as mergers & acquisitions, R&D, product launches, FDA approvals, and geographical expansions to generated more revenue and to remain competitive in the market. For instance, in January 2020, Evotec SE and Bayer AG announced the expansion of their partnership in women's health indications with Celmatix Inc., to develop multiple clinical candidates for the treatment of PCOS. Through this agreement, both companies contributed drug targets and a comprehensive set of high-quality technology platforms to develop innovative treatment options for PCOS.

The Report Covers

Market value data analysis of 2020 and forecast to 2027.

Annualized market revenues ($ million) for each market segment.

Country-wise analysis of major geographical regions.

Key companies operating in the global Polycystic Ovary Syndrome (PCOS) market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.

Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.

Analysis of market entry and market expansion strategies.

Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global PCOS Industry
  • Recovery Scenario of Global PCOS Industry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on key players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global PCOS Market, By Drug Type
    • 5.1.1. Diuretics
    • 5.1.2. Insulin Sensitizing Agents
    • 5.1.3. Antiandrogens
    • 5.1.4. Anti-Depressants
    • 5.1.5. Ornithine Decarboxylase Inhibitors
    • 5.1.6. Anti-Obesity
    • 5.1.7. Oral Contraceptive Pills
  • 5.2. Global PCOS Market, By Diagnosis Type
    • 5.2.1. Ultrasound
    • 5.2.2. Pelvic Exam
    • 5.2.3. Blood Test
  • 5.3. Global PCOS Market, By Treatment Type
    • 5.3.1. Ovarian Wedge Resection
    • 5.3.2. Laparoscopic Ovarian Drilling
    • 5.3.3. Acupuncture
  • 5.4. Global PCOS Market, By Distribution Channel
    • 5.4.1. Hospital Pharmacies
    • 5.4.2. Retail Pharmacies (Online and Offline)
    • 5.4.3. Fertility Clinics

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Russia
    • 6.2.7. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korean
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World
    • 6.4.1. Latin America
    • 6.4.2. Middle East& Africa

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. Astellas Pharma Inc.
  • 7.3. AstraZeneca plc
  • 7.4. AVA Science Inc.
  • 7.5. Bayer AG
  • 7.6. Bristol-Myers Squibb Co.
  • 7.7. Dexa Medica (Dexa Group)
  • 7.8. Ferring B.V.
  • 7.9. GlaxoSmithKline plc
  • 7.10. Merck & Co., Inc.
  • 7.11. Millendo Therapeutics, Inc.
  • 7.12. MyOva
  • 7.13. Novartis AG
  • 7.14. PCOS Diva LLC
  • 7.15. Pharmasure Ltd.
  • 7.16. Sanofi SA
  • 7.17. Sneha Natura
  • 7.18. Teva Pharmaceutical Industries Ltd.
  • 7.19. The Himalaya Drug Co.
  • 7.20. Theralogix, LLC

LIST OF TABLES

  • 1. GLOBAL PCOS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE,2020-2027 ($ MILLION)
  • 2. GLOBAL DIURETICS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 3. GLOBAL INSULIN SENSITIZING AGENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBAL ANTIANDROGENS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBAL ANTI-DEPRESSANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL ORNITHINE DECARBOXYLASE INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 7. GLOBAL ANTI-OBESITY MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL PCOSMARKET RESEARCH AND ANALYSIS BY DIAGNOSIS TYPE, 2020-2027 ($ MILLION)
  • 10. GLOBAL ULTRASOUND FOR PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL PELVIC EXAM FOR PCOS MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
  • 12. GLOBAL BLOOD TEST FOR PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL PCOS MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 14. GLOBAL OVARIAN WEDGE RESECTION IN PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL LAPAROSCOPIC OVARIAN DRILLING IN PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL ACUPUNCTURE IN PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL PCOS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 18. GLOBAL HOSPITAL PHARMACIES IN PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL RETAIL PHARMACIES (ONLINE AND OFFLINE) IN PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 20. GLOBAL FERTILITY CLINICS IN PCOS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 21. NORTH AMERICAN PCOS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 22. NORTH AMERICAN PCOS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE,2020-2027 ($ MILLION)
  • 23. NORTH AMERICAN PCOS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS TYPE, 2020-2027 ($ MILLION)
  • 24. NORTH AMERICAN PCOS MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 25. NORTH AMERICAN PCOS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 26. EUROPEAN PCOS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 27. EUROPEAN PCOS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE,2020-2027 ($ MILLION)
  • 28. EUROPEAN PCOS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS TYPE, 2020-2027 ($ MILLION)
  • 29. EUROPEAN PCOS MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 30. EUROPEAN PCOS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 31. ASIA-PACIFIC PCOS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 32. ASIA-PACIFIC PCOS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE,2020-2027 ($ MILLION)
  • 33. ASIA-PACIFIC PCOS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS TYPE,2020-2027 ($ MILLION)
  • 34. ASIA-PACIFIC PCOS MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 35. ASIA-PACIFIC PCOS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
  • 36. REST OF THE WORLD PCOS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 37. REST OF THE WORLD PCOS MARKET RESEARCH AND ANALYSIS BY DRUG TYPE,2020-2027 ($ MILLION)
  • 38. REST OF THE WORLD PCOS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS TYPE,2020-2027 ($ MILLION)
  • 39. REST OF THE WORLD PCOS MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 40. REST OF THE WORLD PCOS MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)

LIST OF FIGURES

1. IMPACT OF COVID-19 ON GLOBAL PCOS MARKET, 2020-2027 (% MILLION)

2. IMPACT OF COVID-19 ON GLOBAL PCOS MARKET BY SEGMENT, 2020-2027 (% MILLION)

  • 3. RECOVERY OF GLOBAL PCOS MARKET, 2020-2027 (%)
  • 4. GLOBAL PCOS MARKET SHARE BY DRUG TYPE,2020 VS 2027 (%)
  • 5. GLOBAL PCOS MARKET SHARE BY DIAGNOSIS TYPE,2020 VS 2027 (%)
  • 6. GLOBAL PCOS MARKET SHARE BY TREATMENT TYPE,2020 VS 2027 (%)
  • 7. GLOBAL PCOS MARKET SHARE BY DISTRIBUTION CHANNEL,2020 VS 2027 (%)
  • 8. GLOBAL PCOS MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 9. GLOBAL DIURETICS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL INSULIN SENSITIZING AGENTS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 11. GLOBAL ANTIANDROGENS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBAL ANTI-DEPRESSANTS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBAL ORNITHINE DECARBOXYLASE INHIBITORS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 14. GLOBAL ANTI-OBESITY MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 15. GLOBAL ORAL CONTRACEPTIVE PILLS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 16. GLOBAL ULTRASOUND FOR PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 17. GLOBAL PELVIC EXAM FOR PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 18. GLOBAL BLOOD TEST FOR PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 19. GLOBAL OVARIAN WEDGE RESECTION IN PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 20. GLOBAL LAPAROSCOPIC OVARIAN DRILLING IN PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 21. GLOBAL ACUPUNCTURE IN PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 22. GLOBAL HOSPITAL PHARMACIES IN PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 23. GLOBAL RETAIL PHARMACIES (ONLINE AND OFFLINE) IN PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 24. GLOBAL FERTILITY CLINICS IN PCOS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
  • 25. UK PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. FRANCE PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. GERMANY PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. ITALY PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. SPAIN PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 30. REST OF EUROPE PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 31. INDIA PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 32. CHINA PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 33. JAPAN PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 34. SOUTH KOREA PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 35. REST OF ASIA-PACIFIC PCOS MARKET SIZE, 2020-2027 ($ MILLION)
  • 36. REST OF THE WORLD PCOS MARKET SIZE, 2021-2027($ MILLION)